Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infectionGerrit Jan Weverling, Peter Reiß, Ole Kirk et al.|The Lancet|1999Cited by 223
Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping Due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C CoinfectionAmanda Mocroft, Jens Lundgren, Alexandra Phillips et al.|AIDS Research and Human Retroviruses|2005Cited by 35